
Home » BIOGEN IDEC TO EXPAND ONCOLOGY PIPELINE
BIOGEN IDEC TO EXPAND ONCOLOGY PIPELINE
Biogen Idec and Conforma Therapeutics Corporation, a privately held biopharmaceutical company focused on the design and development of novel drugs for the treatment of cancer, recently announced that they have signed a definitive merger agreement for the acquisition of Conforma by Biogen Idec.
Financial News USA
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
08Sep
-
15Sep
-
20Sep
-
21Sep
-
22Sep
-
11Oct